Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018)
Twist Bioscience (TWST) posted quarterly Preferred Stock Liabilities of $290.5 million for Q3 2018, up 1021.56% sequentially from $25.9 million in Q2 2018.
Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Twist Bioscience has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $290.5 million for Q3 2018.
- In Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $290.5 million; the TTM figure through Sep 2018 stood at $290.5 million (changed N/A YoY), while the FY2018 annual figure was $290.5 million, up 690.95% from the prior year.
- Preferred Stock Liabilities advanced to $290.5 million in Q3 2018, from $25.9 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for TWST reached as high as $290.5 million in Q3 2018 and fell as low as $9.1 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Twist Bioscience | 6.31 Bn | 6.14 Bn | 57.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 290.48 Mn |
| Jun 30, 2018 | 25.90 Mn |
| Mar 31, 2018 | 25.90 Mn |
| Dec 31, 2017 | 9.14 Mn |